Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionMcdaniel Terry & Co
Latest Disclosed Ownership3,325 shares
Latest Disclosed Value $ 507,894
Mcdaniel Terry & Co reports 4.92% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 5, 2026 - Mcdaniel Terry & Co filed a 13F-HR form disclosing ownership of 3,325 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $427,262 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 3,169 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 4.92% during the quarter. The current value of the position is $402,325 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F Novartis ADR 66987V109 3,325 156 4.92 508 16.28 0.0431
2026-02-10 2025-12-31 13F Novartis ADR ADR 66987V109 3,169 -8 -0.25 437 7.13 0.0380
2025-10-22 2025-09-30 13F Novartis ADR ADR 66987V109 3,177 -323 -9.23 407 -3.78 0.0328
2025-07-31 2025-06-30 13F Novartis ADR ADR 66987V109 3,500 -395 -10.14 424 0.0347
2025-04-24 2025-03-31 13F Novartis COM 66987V109 3,895 -45 -1.14 0 0.0380
2025-02-03 2024-12-31 13F Novartis COM 66987V109 3,940 -2,250 -36.35 0 0.0314
2024-10-23 2024-09-30 13F Novartis COM 66987V109 6,190 370 6.36 1 0.0596
2024-08-05 2024-06-30 13F Novartis COM 66987V109 5,820 -164 -2.74 1 0.0541
2024-04-29 2024-03-31 13F Novartis COM 66987V109 5,984 -5,527 -48.01 1 -100.00 0.0515
2024-01-24 2023-12-31 13F Novartis COM 66987V109 11,511 0 0.00 1 0.00 0.1112
2023-10-23 2023-09-30 13F Novartis COM 66987V109 11,511 0 0.00 1 0.00 0.1222
2023-07-21 2023-06-30 13F Novartis COM 66987V109 11,511 -12 -0.10 1 0.00 0.1182
2023-05-05 2023-03-31 13F Novartis COM 66987V109 11,523 -175 -1.50 1 0.00 0.1155
2023-01-23 2022-12-31 13F Novartis COM 66987V109 11,698 -590 -4.80 1 -99.89 0.1234
2022-10-06 2022-09-30 13F Novartis COM 66987V109 12,288 -473 -3.71 934 -13.44 0.1210
2022-07-28 2022-06-30 13F Novartis COM 66987V109 12,761 -5,861 -31.47 1,079 -33.97 0.1332
2022-04-27 2022-03-31 13F Novartis COM 66987V109 18,622 -150,080 -88.96 1,634 -88.93 0.1766
2022-01-20 2021-12-31 13F Novartis COM 66987V109 168,702 -43,773 -20.60 14,756 -15.08 1.4778
2021-12-06 2021-09-30 13F Novartis COM 66987V109 212,475 6,455 3.13 17,376 -7.56 2.0271
2021-08-11 2021-06-30 13F Novartis COM 66987V109 206,020 2,861 1.41 18,797 8.24 2.1665
2021-05-17 2021-03-31 13F Novartis COM 66987V109 203,159 2,090 1.04 17,366 -8.54 2.1254
2021-02-12 2020-12-31 13F Novartis COM 66987V109 201,069 3,981 2.02 18,987 10.78 2.4076
2020-11-09 2020-09-30 13F Novartis COM 66987V109 197,088 934 0.48 17,139 0.04 2.4255
2020-08-13 2020-06-30 13F Novartis COM 66987V109 196,154 -5,066 -2.52 17,132 3.26 2.6096
2020-05-08 2020-03-31 13F Novartis COM 66987V109 201,220 6,101 3.13 16,591 -10.20 3.0511
2020-02-03 2019-12-31 13F Novartis COM 66987V109 195,119 -1,744 -0.89 18,476 8.00 2.7598
2019-11-07 2019-09-30 13F Novartis COM 66987V109 196,863 -2,395 -1.20 17,107 -5.97 2.7476
2019-08-12 2019-06-30 13F Novartis COM 66987V109 199,258 1,368 0.69 18,194 -4.37 3.0180
2019-05-09 2019-03-31 13F Novartis COM 66987V109 197,890 754 0.38 19,025 12.47 3.2567
2019-02-07 2018-12-31 13F Novartis COM 66987V109 197,136 -671 -0.34 16,916 -0.75 3.2752
2018-11-13 2018-09-30 13F Novartis COM 66987V109 197,807 677 0.34 17,043 14.45 2.8757
2018-08-13 2018-06-30 13F Novartis COM 66987V109 197,130 2,018 1.03 14,891 -5.60 2.7368
2018-05-11 2018-03-31 13F Novartis COM 66987V109 195,112 -444 -0.23 15,775 -3.92 2.8834
2018-02-09 2017-12-31 13F Novartis COM 66987V109 195,556 -559 -0.29 16,419 -2.48 2.9047
2017-11-13 2017-09-30 13F Novartis COM 66987V109 196,115 -5,550 -2.75 16,836 0.02 3.1845
2017-08-10 2017-06-30 13F Novartis COM 66987V109 201,665 355 0.18 16,833 12.59 3.2650
2017-05-12 2017-03-31 13F Novartis COM 66987V109 201,310 7,512 3.88 14,951 5.92 2.9271
2017-02-10 2016-12-31 13F Novartis COM 66987V109 193,798 146 0.08 14,116 -7.68 2.9300
2016-11-10 2016-09-30 13F Novartis COM 66987V109 193,652 1,537 0.80 15,291 -3.53 3.2733
2016-08-15 2016-06-30 13F Novartis COM 66987V109 192,115 3,292 1.74 15,851 15.89 3.5609
2016-05-16 2016-03-31 13F Novartis COM 66987V109 188,823 8,583 4.76 13,678 -11.80 3.2185
2016-02-12 2015-12-31 13F Novartis COM 66987V109 180,240 -855 -0.47 15,508 -6.84 4.0430
2015-11-12 2015-09-30 13F Novartis COM 66987V109 181,095 2,250 1.26 16,646 -5.36 4.6369
2015-08-07 2015-06-30 13F Novartis COM 66987V109 178,845 3,343 1.90 17,588 1.63 4.4298
2015-05-08 2015-03-31 13F Novartis COM 66987V109 175,502 1,098 0.63 17,306 7.09 4.2327
2015-02-17 2014-12-31 13F Novartis COM 66987V109 174,404 1,714 0.99 16,160 -0.58 3.8191
2014-11-13 2014-09-30 13F Novartis COM 66987V109 172,690 -2,375 -1.36 16,255 2.56 3.8865
2014-08-11 2014-06-30 13F Novartis COM 66987V109 175,065 1,507 0.87 15,849 7.41 3.7732
2014-05-14 2014-03-31 13F Novartis COM 66987V109 173,558 1,147 0.67 14,756 6.48 3.7482
2014-02-13 2013-12-31 13F Novartis COM 66987V109 172,411 10,357 6.39 13,858 11.48 3.5019
2013-11-13 2013-09-30 13F Novartis COM 66987V109 162,054 2,515 1.58 12,431 10.19 3.4098
2013-08-05 2013-06-30 13F Novartis COM 66987V109 159,539 159,539 11,281 3.3457
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.